These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 2966483)

  • 1. Cyclosporine pharmacokinetics and pharmacodynamics after oral administration in the rat.
    Didlake RH; Kim EK; Grevel J; Jarolimek L; Kahan BD
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):692-5. PubMed ID: 2966483
    [No Abstract]   [Full Text] [Related]  

  • 2. Pharmacodynamics of cyclosporine.
    Kahan BD; Yoshimura N; Pellis NR; Burstain T; Van Buren CT; Leinikki P; Schreiber RD; Roesel TR; Kerman RH
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):238-51. PubMed ID: 2947366
    [No Abstract]   [Full Text] [Related]  

  • 3. Induction of unresponsiveness after local low-dose cyclosporine administration.
    Stepkowski S; Goto S; Reynolds K; Ito T; Kahan BD
    Transplant Proc; 1989 Feb; 21(1 Pt 1):1120-2. PubMed ID: 2650072
    [No Abstract]   [Full Text] [Related]  

  • 4. In-vitro mechanisms responsible for prolonged rat cardiac allograft survival induced by ultraviolet irradiated donor-specific blood and cyclosporine.
    Oluwole SF; Chabot J; Pepino P; Reemtsma K; Hardy MA
    Transplant Proc; 1987 Oct; 19(5):4331-3. PubMed ID: 2960059
    [No Abstract]   [Full Text] [Related]  

  • 5. Immunosuppressants suppressing signal 2 of T-cell activation enable CsA to induce operational transplantation tolerance in a strongly immunogenic heart allograft model in rats.
    Lin Y; Goebels J; Vandeputte M; Waer M
    Transplant Proc; 1996 Apr; 28(2):977-8. PubMed ID: 8623485
    [No Abstract]   [Full Text] [Related]  

  • 6. The relationship of immunological responsiveness to suppression of cellular responses by cyclosporine in vitro.
    MacSween JM; Cohen AD; Eastwood SL; Fernandez LA
    Transplant Proc; 1987 Feb; 19(1 Pt 2):1202-4. PubMed ID: 2978876
    [No Abstract]   [Full Text] [Related]  

  • 7. Mechanism of prolonged allograft survival induced by ultraviolet B irradiated donor-specific blood transfusions and cyclosporine.
    Oluwole SF; Reemtsma K; Hardy MA
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):1097-101. PubMed ID: 2968697
    [No Abstract]   [Full Text] [Related]  

  • 8. Synergistic effects of cyclosporine and rabbit antithymocyte sera on suppression of the one-way allogeneic mixed lymphocyte response.
    Brady HR; Peters P; Cardella CJ
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):229-32. PubMed ID: 2966478
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of the immune system on cyclosporine absorption.
    Luke DR
    Xenobiotica; 1991 Jun; 21(6):817-24. PubMed ID: 1949911
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolongation of rat renal allograft survival by injection of a small dose of cyclosporine into the thoracic duct.
    Nakaji K; Nakata T; Yasumura T; Ohmori Y; Oka T; Takada K; Muranishi S
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):298-300. PubMed ID: 3284072
    [No Abstract]   [Full Text] [Related]  

  • 11. The effect of obesity on cyclosporine pharmacokinetics in uremic patients.
    Flechner SM; Kolbeinsson MC; Lum B; Tam J; Moran T
    Transplant Proc; 1989 Feb; 21(1 Pt 2):1446-8. PubMed ID: 2652464
    [No Abstract]   [Full Text] [Related]  

  • 12. Cyclosporine coverage during the risk period leads to 100% long-term graft acceptance in the rat.
    Lim SM; White DJ; Calne RY
    Transplant Proc; 1988 Jun; 20(3 Suppl 3):1013-5. PubMed ID: 3291211
    [No Abstract]   [Full Text] [Related]  

  • 13. Renal allograft survival in the baboon using a pretreatment protocol with cyclosporine.
    Smit JA; Drielsma RF; Myburgh JA; Laupacis A; Stiller CR
    Transplantation; 1983 Aug; 36(2):121-4. PubMed ID: 6224320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetics and pharmacodynamics of cyclosporine.
    Kahan BD
    Transplant Proc; 1989 Jun; 21(3 Suppl 1):9-15. PubMed ID: 2662538
    [No Abstract]   [Full Text] [Related]  

  • 15. Improvement of peroral absorption of cyclosporine A by microemulsions.
    Ritschel WA; Adolph S; Ritschel GB; Schroeder T
    Methods Find Exp Clin Pharmacol; 1990 Mar; 12(2):127-34. PubMed ID: 2319836
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunological study of cyclosporine in heterotopic transplantation of canine hearts.
    Suzuki S; Mizuochi I; Amemiya H
    Transplantation; 1985 May; 39(5):565-8. PubMed ID: 3158109
    [No Abstract]   [Full Text] [Related]  

  • 17. A longitudinal study of the pharmacokinetics of cyclosporine A and in vitro lymphocyte responses in renal transplant patients.
    Tufveson G; Odlind B; Sjöberg O; Lindberg A; Gabrielsson J; Lindström B; Lithell H; Selinus I; Tötterman T; Wahlberg J
    Transplant Proc; 1986 Dec; 18(6 Suppl 5):16-24. PubMed ID: 2947364
    [No Abstract]   [Full Text] [Related]  

  • 18. Influence of biliary T tube clamping on cyclosporine pharmacokinetics in liver transplant recipients.
    Tredger JM; Naoumov NV; Steward CM; O'Grady JG; Grevel J; Niven AA; Kelman AW; Whiting B; Williams R
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):512-5. PubMed ID: 3284098
    [No Abstract]   [Full Text] [Related]  

  • 19. Cyclosporine-induced transplantation unresponsiveness in rat cardiac allograft recipients: in vitro determination of helper and suppressor activity.
    Uhteg LC; Salomon DR; Rocher LL; Kupiec-Weglinski JW; Araujo JL; Rubin MF; Tilney NL; Carpenter CB
    J Immunol; 1985 Sep; 135(3):1800-5. PubMed ID: 3160780
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro effects of cyclosporine A on allogeneic and autologous lymphocyte stimulation: influence of HLA phenotypes.
    Scorza R; Vanoli M; Cigognini A; Fabio G; De Bernardi B; Zanussi C
    Transplant Proc; 1988 Apr; 20(2 Suppl 2):122-4. PubMed ID: 2966475
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.